Share Price and Basic Stock Data
Last Updated: December 27, 2025, 8:28 pm
| PEG Ratio | 0.85 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balmer Lawrie & Company Ltd operates in the diversified industry, showcasing a robust revenue trajectory. The company reported sales of ₹2,312 Cr for the fiscal year ending March 2023, which rose to ₹2,328 Cr in March 2024 and further increased to ₹2,505 Cr in March 2025. This consistent growth reflects a compound annual growth rate (CAGR) that highlights the company’s resilience and adaptability in a competitive market. Quarterly sales also demonstrate variability, with the most recent quarter of June 2025 recording sales of ₹681 Cr, up from ₹577 Cr in March 2025. This upward trend indicates effective demand management and operational strategies. Despite some fluctuations in quarterly figures, such as a dip to ₹514 Cr in December 2022, the overall revenue performance is commendable. With a trailing twelve-month revenue of ₹2,555 Cr, the company showcases its ability to maintain a strong market presence.
Profitability and Efficiency Metrics
Balmer Lawrie’s profitability metrics are solid, with a net profit of ₹259 Cr for the fiscal year ending March 2025, reflecting a significant rise from ₹168 Cr in March 2023. The operating profit margin (OPM) stood at 12% for the latest fiscal year, indicating efficient cost management relative to sales. The company’s return on equity (ROE) is reported at 14%, while the return on capital employed (ROCE) is slightly higher at 14.8%, both of which are competitive within the diversified sector. The interest coverage ratio (ICR) of 13.67x suggests that the company comfortably meets its interest obligations, reinforcing financial health. The cash conversion cycle (CCC) of 33 days indicates that Balmer Lawrie efficiently manages its receivables and payables, optimizing working capital. Overall, these metrics paint a picture of a company that is not only profitable but also effectively managing its operational efficiencies.
Balance Sheet Strength and Financial Ratios
Balmer Lawrie’s balance sheet reflects a strong financial position, with total assets reported at ₹3,040 Cr as of March 2025, up from ₹2,662 Cr in March 2023. The company’s reserves have also increased to ₹1,798 Cr, showcasing a healthy retention of earnings. Total borrowings stood at ₹106 Cr, which is relatively low compared to the overall capital structure, indicating a conservative approach to leverage. The debt-to-equity ratio remains low at 0.03, suggesting minimal reliance on debt financing. The price-to-book value (P/BV) ratio is reported at 1.60x, which is reasonable compared to typical sector norms. Furthermore, the current ratio of 2.27x and quick ratio of 1.99x indicate excellent liquidity, allowing the company to meet short-term obligations comfortably. These financial ratios collectively demonstrate Balmer Lawrie’s sound financial health and prudent capital management strategies.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Balmer Lawrie indicates a stable investor base, with the public holding 95.94% of the shares as of September 2025. Foreign institutional investors (FIIs) have increased their stake from 1.31% in December 2022 to 2.26% by September 2025, reflecting growing confidence in the company’s prospects. Domestic institutional investors (DIIs) have maintained a consistent presence, currently holding 1.79% of the shares. The increase in the number of shareholders from 93,740 in December 2022 to 111,490 in September 2025 further underscores rising investor interest. This broad base of public ownership, combined with increasing institutional participation, signals a positive outlook for the company. However, the lack of promoter holding may raise concerns regarding long-term strategic direction, necessitating careful monitoring of governance and operational decisions.
Outlook, Risks, and Final Insight
Looking ahead, Balmer Lawrie is well-positioned to capitalize on its operational strengths and market opportunities. The company’s solid revenue growth and robust profitability metrics indicate a positive trajectory. However, risks such as fluctuating raw material costs and potential market volatility remain pertinent. Additionally, the company’s reliance on public and institutional investors without significant promoter backing may pose governance challenges. Should Balmer Lawrie continue to enhance operational efficiencies and maintain strong financial health, it could further solidify its market position. Conversely, any significant downturn in demand or adverse economic conditions could impact its profitability and growth strategy. Overall, the company demonstrates a balanced risk-reward profile, appealing to both growth-oriented and value-focused investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 8,617 Cr. | 1,223 | 1,639/842 | 20.8 | 397 | 0.53 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 19,395 Cr. | 1,244 | 1,502/903 | 27.2 | 463 | 0.72 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,153 Cr. | 184 | 238/147 | 11.9 | 114 | 4.61 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 38,966 Cr. | 34,575 | 37,000/25,714 | 63.7 | 1,906 | 0.46 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 17,532.75 Cr | 9,306.50 | 30.90 | 720.00 | 1.58% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 648 | 551 | 514 | 608 | 592 | 586 | 585 | 577 | 638 | 639 | 630 | 608 | 681 |
| Expenses | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 546 | 514 | 597 |
| Operating Profit | 61 | 39 | 50 | 52 | 65 | 75 | 74 | 91 | 64 | 70 | 84 | 95 | 83 |
| OPM % | 9% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 13% | 16% | 12% |
| Other Income | 8 | 8 | 3 | 17 | 10 | 13 | 11 | 18 | 12 | 11 | 9 | 18 | 9 |
| Interest | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 |
| Profit before tax | 51 | 29 | 34 | 51 | 54 | 69 | 64 | 88 | 56 | 62 | 68 | 90 | 71 |
| Tax % | 22% | 37% | 29% | 51% | 22% | 31% | 24% | 31% | 20% | 30% | 29% | 35% | 27% |
| Net Profit | 55 | 34 | 35 | 43 | 56 | 63 | 66 | 73 | 63 | 61 | 62 | 74 | 67 |
| EPS in Rs | 3.28 | 2.05 | 2.11 | 2.61 | 3.35 | 3.73 | 3.90 | 4.31 | 3.73 | 3.66 | 3.77 | 4.39 | 4.03 |
Last Updated: August 20, 2025, 1:10 pm
Below is a detailed analysis of the quarterly data for Balmer Lawrie & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 681.00 Cr.. The value appears strong and on an upward trend. It has increased from 608.00 Cr. (Mar 2025) to 681.00 Cr., marking an increase of 73.00 Cr..
- For Expenses, as of Jun 2025, the value is 597.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 597.00 Cr., marking an increase of 83.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 12.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 71.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 71.00 Cr., marking a decrease of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to 27.00%, marking a decrease of 8.00%.
- For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.03. The value appears to be declining and may need further review. It has decreased from 4.39 (Mar 2025) to 4.03, marking a decrease of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,120 | 3,254 | 1,591 | 1,702 | 1,720 | 1,772 | 1,532 | 1,526 | 2,051 | 2,312 | 2,328 | 2,505 | 2,555 |
| Expenses | 2,908 | 3,031 | 1,386 | 1,492 | 1,502 | 1,539 | 1,342 | 1,385 | 1,882 | 2,109 | 2,023 | 2,192 | 2,226 |
| Operating Profit | 212 | 223 | 205 | 211 | 219 | 233 | 189 | 141 | 169 | 202 | 305 | 313 | 329 |
| OPM % | 7% | 7% | 13% | 12% | 13% | 13% | 12% | 9% | 8% | 9% | 13% | 12% | 13% |
| Other Income | 70 | 64 | 63 | 56 | 51 | 51 | 51 | 49 | 37 | 37 | 51 | 50 | 46 |
| Interest | 24 | 23 | 5 | 5 | 4 | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 29 |
| Depreciation | 35 | 46 | 24 | 26 | 27 | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 62 |
| Profit before tax | 222 | 218 | 240 | 236 | 238 | 247 | 173 | 123 | 136 | 164 | 274 | 276 | 285 |
| Tax % | 30% | 30% | 32% | 34% | 31% | 35% | 32% | 33% | 35% | 35% | 27% | 29% | |
| Net Profit | 156 | 152 | 164 | 155 | 165 | 197 | 155 | 115 | 134 | 168 | 236 | 259 | 258 |
| EPS in Rs | 9.09 | 8.89 | 9.58 | 9.05 | 9.66 | 11.65 | 9.43 | 7.04 | 8.05 | 10.05 | 14.02 | 15.55 | 15.50 |
| Dividend Payout % | 27% | 34% | 35% | 52% | 69% | 63% | 80% | 85% | 81% | 75% | 61% | 55% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.56% | 7.89% | -5.49% | 6.45% | 19.39% | -21.32% | -25.81% | 16.52% | 25.37% | 40.48% | 9.75% |
| Change in YoY Net Profit Growth (%) | 0.00% | 10.46% | -13.38% | 11.94% | 12.94% | -40.71% | -4.49% | 42.33% | 8.85% | 15.10% | -30.73% |
Balmer Lawrie & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 25% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 114 | 114 | 114 | 171 | 171 | 171 | 171 | 171 | 171 | 171 |
| Reserves | 953 | 1,015 | 1,210 | 1,247 | 1,342 | 1,406 | 1,383 | 1,371 | 1,416 | 1,510 | 1,650 | 1,798 | 1,773 |
| Borrowings | 175 | 197 | 0 | 0 | 15 | 81 | 120 | 125 | 122 | 121 | 113 | 106 | 237 |
| Other Liabilities | 724 | 670 | 559 | 669 | 720 | 682 | 660 | 712 | 736 | 860 | 939 | 966 | 1,049 |
| Total Liabilities | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
| Fixed Assets | 464 | 577 | 393 | 397 | 410 | 568 | 770 | 767 | 767 | 760 | 751 | 737 | 789 |
| CWIP | 77 | 12 | 11 | 63 | 138 | 117 | 24 | 32 | 11 | 28 | 52 | 67 | 79 |
| Investments | 0 | 0 | 248 | 271 | 293 | 325 | 375 | 386 | 436 | 518 | 565 | 632 | 669 |
| Other Assets | 1,339 | 1,322 | 1,146 | 1,299 | 1,350 | 1,272 | 1,165 | 1,194 | 1,231 | 1,356 | 1,505 | 1,604 | 1,693 |
| Total Assets | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 | 3,230 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 171.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 171.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,798.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 237.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 106.00 Cr. (Mar 2025) to 237.00 Cr., marking an increase of 131.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,049.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 966.00 Cr. (Mar 2025) to 1,049.00 Cr., marking an increase of 83.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 789.00 Cr.. The value appears strong and on an upward trend. It has increased from 737.00 Cr. (Mar 2025) to 789.00 Cr., marking an increase of 52.00 Cr..
- For CWIP, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 669.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2025) to 669.00 Cr., marking an increase of 37.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,693.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,604.00 Cr. (Mar 2025) to 1,693.00 Cr., marking an increase of 89.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,040.00 Cr. (Mar 2025) to 3,230.00 Cr., marking an increase of 190.00 Cr..
Notably, the Reserves (1,773.00 Cr.) exceed the Borrowings (237.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 37.00 | 26.00 | 205.00 | 211.00 | 204.00 | 152.00 | 69.00 | 16.00 | 47.00 | 81.00 | 192.00 | 207.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 53 | 53 | 60 | 57 | 57 | 65 | 69 | 56 | 57 | 67 | 70 |
| Inventory Days | 48 | 48 | 77 | 51 | 46 | 47 | 57 | 59 | 51 | 46 | 66 | 67 |
| Days Payable | 53 | 44 | 144 | 104 | 108 | 96 | 88 | 100 | 69 | 68 | 108 | 104 |
| Cash Conversion Cycle | 57 | 56 | -14 | 8 | -4 | 8 | 35 | 28 | 38 | 35 | 25 | 33 |
| Working Capital Days | 23 | 23 | -24 | 30 | 39 | 44 | 49 | 30 | 49 | 39 | 39 | 62 |
| ROCE % | 22% | 20% | 20% | 18% | 17% | 16% | 11% | 8% | 8% | 10% | 16% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 92,092 | 0.26 | 2.25 | 92,092 | 2025-04-22 17:25:41 | 0% |
| Groww Nifty Total Market Index Fund | 394 | 0.01 | 0.01 | 394 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Diluted EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Cash EPS (Rs.) | 14.92 | 15.11 | 9.57 | 8.49 | 8.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Revenue From Operations / Share (Rs.) | 147.11 | 136.79 | 135.76 | 120.19 | 89.41 |
| PBDIT / Share (Rs.) | 21.20 | 20.80 | 13.98 | 12.06 | 11.09 |
| PBIT / Share (Rs.) | 17.68 | 17.34 | 10.66 | 8.79 | 7.88 |
| PBT / Share (Rs.) | 16.13 | 16.05 | 9.61 | 8.00 | 7.18 |
| Net Profit / Share (Rs.) | 11.39 | 11.65 | 6.25 | 5.23 | 4.83 |
| NP After MI And SOA / Share (Rs.) | 15.55 | 15.30 | 10.05 | 7.88 | 6.74 |
| PBDIT Margin (%) | 14.41 | 15.20 | 10.29 | 10.03 | 12.40 |
| PBIT Margin (%) | 12.01 | 12.67 | 7.85 | 7.31 | 8.80 |
| PBT Margin (%) | 10.96 | 11.73 | 7.07 | 6.65 | 8.03 |
| Net Profit Margin (%) | 7.74 | 8.52 | 4.60 | 4.35 | 5.40 |
| NP After MI And SOA Margin (%) | 10.57 | 11.18 | 7.40 | 6.55 | 7.54 |
| Return on Networth / Equity (%) | 13.50 | 14.36 | 10.22 | 8.48 | 7.47 |
| Return on Capital Employeed (%) | 12.90 | 13.71 | 9.02 | 7.83 | 7.27 |
| Return On Assets (%) | 8.74 | 9.10 | 6.45 | 5.50 | 4.84 |
| Long Term Debt / Equity (X) | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 |
| Total Debt / Equity (X) | 0.03 | 0.04 | 0.05 | 0.05 | 0.06 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.90 | 0.94 | 0.71 |
| Current Ratio (X) | 2.27 | 2.08 | 2.09 | 2.31 | 2.24 |
| Quick Ratio (X) | 1.99 | 1.81 | 1.77 | 1.93 | 1.94 |
| Inventory Turnover Ratio (X) | 13.04 | 5.07 | 7.88 | 5.34 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 54.65 | 49.03 | 64.67 | 76.14 | 111.23 |
| Dividend Payout Ratio (CP) (%) | 44.55 | 39.98 | 48.61 | 53.84 | 75.30 |
| Earning Retention Ratio (%) | 45.35 | 50.97 | 35.33 | 23.86 | -11.23 |
| Cash Earning Retention Ratio (%) | 55.45 | 60.02 | 51.39 | 46.16 | 24.70 |
| Interest Coverage Ratio (X) | 13.67 | 16.13 | 13.33 | 15.17 | 15.92 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 10.04 | 6.96 | 7.58 | 7.93 |
| Enterprise Value (Cr.) | 2796.58 | 3661.98 | 1567.62 | 1642.42 | 1805.18 |
| EV / Net Operating Revenue (X) | 1.11 | 1.57 | 0.67 | 0.79 | 1.18 |
| EV / EBITDA (X) | 7.71 | 10.30 | 6.56 | 7.97 | 9.51 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| Retention Ratios (%) | 45.34 | 50.96 | 35.32 | 23.85 | -11.23 |
| Price / BV (X) | 1.60 | 2.24 | 1.13 | 1.21 | 1.43 |
| Price / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| EarningsYield | 0.08 | 0.06 | 0.09 | 0.06 | 0.05 |
After reviewing the key financial ratios for Balmer Lawrie & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.92. This value is within the healthy range. It has decreased from 15.11 (Mar 24) to 14.92, marking a decrease of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 147.11. It has increased from 136.79 (Mar 24) to 147.11, marking an increase of 10.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.20. This value is within the healthy range. It has increased from 20.80 (Mar 24) to 21.20, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 17.34 (Mar 24) to 17.68, marking an increase of 0.34.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.13. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 16.13, marking an increase of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 11.65 (Mar 24) to 11.39, marking a decrease of 0.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For PBDIT Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.20 (Mar 24) to 14.41, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 12.01, marking a decrease of 0.66.
- For PBT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 10.96, marking a decrease of 0.77.
- For Net Profit Margin (%), as of Mar 25, the value is 7.74. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.74, marking a decrease of 0.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.57, marking a decrease of 0.61.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.50. This value is below the healthy minimum of 15. It has decreased from 14.36 (Mar 24) to 13.50, marking a decrease of 0.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has decreased from 13.71 (Mar 24) to 12.90, marking a decrease of 0.81.
- For Return On Assets (%), as of Mar 25, the value is 8.74. This value is within the healthy range. It has decreased from 9.10 (Mar 24) to 8.74, marking a decrease of 0.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has increased from 0.84 (Mar 24) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 2.08 (Mar 24) to 2.27, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 1.99, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.04. This value exceeds the healthy maximum of 8. It has increased from 5.07 (Mar 24) to 13.04, marking an increase of 7.97.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.65. This value exceeds the healthy maximum of 50. It has increased from 49.03 (Mar 24) to 54.65, marking an increase of 5.62.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 44.55. This value is within the healthy range. It has increased from 39.98 (Mar 24) to 44.55, marking an increase of 4.57.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.35. This value is within the healthy range. It has decreased from 50.97 (Mar 24) to 45.35, marking a decrease of 5.62.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 55.45. This value is within the healthy range. It has decreased from 60.02 (Mar 24) to 55.45, marking a decrease of 4.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 16.13 (Mar 24) to 13.67, marking a decrease of 2.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has decreased from 10.04 (Mar 24) to 8.34, marking a decrease of 1.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,796.58. It has decreased from 3,661.98 (Mar 24) to 2,796.58, marking a decrease of 865.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.11, marking a decrease of 0.46.
- For EV / EBITDA (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 7.71, marking a decrease of 2.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 45.34. This value is within the healthy range. It has decreased from 50.96 (Mar 24) to 45.34, marking a decrease of 5.62.
- For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.60, marking a decrease of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.08, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie & Company Ltd:
- Net Profit Margin: 7.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.9% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.5% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.9 (Industry average Stock P/E: 30.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Adhip Nath Palchaudhuri | Chairman & Managing Director |
| Mr. Saurav Dutta | Director - Finance & CFO |
| Dr. Vandana Minda Heda | Independent Director |
| Mr. Rajeev Kumar | Government Nominee Director |
| Mr. Raja Mani Uthayaraja | Director - Manufacturing Businesses |
| Mr. Abhijit Ghosh | Director - HR & Corporate Affairs |
| Mr. Romon Sebastian Louis | Director - Service Businesses |
| Mr. Harishkumar Madhusudan Joshi | Independent Director |
FAQ
What is the intrinsic value of Balmer Lawrie & Company Ltd?
Balmer Lawrie & Company Ltd's intrinsic value (as of 27 December 2025) is 158.94 which is 13.62% lower the current market price of 184.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,153 Cr. market cap, FY2025-2026 high/low of 238/147, reserves of ₹1,773 Cr, and liabilities of 3,230 Cr.
What is the Market Cap of Balmer Lawrie & Company Ltd?
The Market Cap of Balmer Lawrie & Company Ltd is 3,153 Cr..
What is the current Stock Price of Balmer Lawrie & Company Ltd as on 27 December 2025?
The current stock price of Balmer Lawrie & Company Ltd as on 27 December 2025 is 184.
What is the High / Low of Balmer Lawrie & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie & Company Ltd stocks is 238/147.
What is the Stock P/E of Balmer Lawrie & Company Ltd?
The Stock P/E of Balmer Lawrie & Company Ltd is 11.9.
What is the Book Value of Balmer Lawrie & Company Ltd?
The Book Value of Balmer Lawrie & Company Ltd is 114.
What is the Dividend Yield of Balmer Lawrie & Company Ltd?
The Dividend Yield of Balmer Lawrie & Company Ltd is 4.61 %.
What is the ROCE of Balmer Lawrie & Company Ltd?
The ROCE of Balmer Lawrie & Company Ltd is 14.8 %.
What is the ROE of Balmer Lawrie & Company Ltd?
The ROE of Balmer Lawrie & Company Ltd is 14.0 %.
What is the Face Value of Balmer Lawrie & Company Ltd?
The Face Value of Balmer Lawrie & Company Ltd is 10.0.